Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 16 07 2020
accepted: 01 03 2021
pubmed: 12 3 2021
medline: 31 8 2021
entrez: 11 3 2021
Statut: ppublish

Résumé

The mortality attributable to ICU-acquired bloodstream infection (BSI) differs between studies due to statistical methods used for cohort matching. Propensity-score matching has never been used to avoid eventual bias when studying BSI attributable mortality in the ICU. We conducted an observational prospective study over a 4-year period, on patients admitted for at least 48 h in 2 intensive care units. Based on risk factors for death in the ICU and for BSI, each patient with BSI was matched with 3 patients without BSI using propensity-score matching. We performed a competitive risk analysis to study BSI mortality attributable fraction. Of 2464 included patients, 71 (2.9%) had a BSI. Propensity-score matching was highly effective and group characteristics were fully balanced. Crude mortality was 36.6% in patients with BSI and 21.6% in propensity-score matched patients (p=0.018). Attributable mortality of BSI was 2.3% [1.2-4.0] and number needed to harm was 6.7. With Fine and Gray model, a higher risk for death was observed in patients with BSI than in propensity-score matched patients (sub distribution Hazard Ratio (sdHR) = 2.11; 95% CI [1.32-3.37] p = 0.002). Patients with BSI had a higher risk for death and BSI attributable mortality fraction was 2.3%.

Identifiants

pubmed: 33694037
doi: 10.1007/s10096-021-04215-4
pii: 10.1007/s10096-021-04215-4
pmc: PMC7945601
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1673-1680

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Medicine (Baltimore). 2014 Oct;93(17):298-309
pubmed: 25398065
Crit Care. 2011;15(2):R100
pubmed: 21418635
J Perinatol. 2002 Mar;22(2):137-43
pubmed: 11896519
Am J Infect Control. 1988 Jun;16(3):128-40
pubmed: 2841893
J Hosp Infect. 2008 May;69(1):56-61
pubmed: 18353495
Am J Epidemiol. 2009 Jul 15;170(2):244-56
pubmed: 19494242
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Antimicrob Agents Chemother. 2005 Feb;49(2):760-6
pubmed: 15673761
J Antimicrob Chemother. 2015 Jan;70(1):273-8
pubmed: 25190722
J Infect. 2017 Feb;74(2):131-141
pubmed: 27838521
Clin Infect Dis. 2006 Apr 15;42(8):1118-26
pubmed: 16575729
Eur J Clin Microbiol Infect Dis. 2020 May;39(5):889-895
pubmed: 31898797
Am J Respir Crit Care Med. 1999 Sep;160(3):976-81
pubmed: 10471627
Chest. 2003 Apr;123(4):1208-13
pubmed: 12684313
Stat Med. 2007 May 20;26(11):2389-430
pubmed: 17031868
Am J Respir Crit Care Med. 2001 Jun;163(7):1584-90
pubmed: 11401878
Infect Control Hosp Epidemiol. 2007 Jan;28(1):31-5
pubmed: 17315338
Curr Opin Crit Care. 2011 Oct;17(5):464-71
pubmed: 21844801
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531

Auteurs

Nicolas Massart (N)

Service de Réanimation, CH de St BRIEUC, 10, rue Marcel Proust, 22000, Saint-Brieuc, France. nicolasmassart@hotmail.fr.
Faculté de Médecine, Université Rennes 1, Biosit, F-35043, Rennes, France. nicolasmassart@hotmail.fr.
Service de maladie infectieuse et de réanimation médicale CHU de rennes, 2, rue Henri le Guilloux, 35000, Rennes, France. nicolasmassart@hotmail.fr.

Guilhem Wattecamps (G)

Service de Réanimation, CH de QUIMPER, 14bis Avenue Yves Thépot, 29107, Quimper, France.

Mikael Moriconi (M)

Service de Réanimation, CH de QUIMPER, 14bis Avenue Yves Thépot, 29107, Quimper, France.

Pierre Fillatre (P)

Service de Réanimation, CH de St BRIEUC, 10, rue Marcel Proust, 22000, Saint-Brieuc, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH